Frontiers Molecular mechanisms of immunotherapy resistance in
![Frontiers Molecular mechanisms of immunotherapy resistance in](https://www.frontiersin.org/files/Articles/1153990/fimmu-14-1153990-HTML/image_m/fimmu-14-1153990-g001.jpg)
The emergence of immunotherapy has profoundly changed the treatment model for triple-negative breast cancer (TNBC). But the heterogeneity of this disease res
V One Technologies On X: Greetings! We Are Looking For A, 42% OFF
![](https://www.frontiersin.org/files/Articles/613815/fimmu-11-613815-HTML/image_m/fimmu-11-613815-g001.jpg)
Frontiers Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
![](https://www.frontiersin.org/files/Articles/795547/fonc-11-795547-HTML/image_m/fonc-11-795547-g001.jpg)
Frontiers Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13578-023-01073-9/MediaObjects/13578_2023_1073_Fig2_HTML.png)
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms, Cell & Bioscience
![](https://www.frontiersin.org/files/Articles/1239013/fmmed-03-1239013-HTML/image_m/fmmed-03-1239013-g001.jpg)
Frontiers Editorial: CAR T-cells: novel therapeutic approaches in the new era of cancer immunotherapy
![](https://www.frontiersin.org/files/Articles/1268745/fimmu-14-1268745-HTML/image_m/fimmu-14-1268745-g001.jpg)
Frontiers Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications
![](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01990/article_deploy/html/images/pharmaceutics-14-01990-g001.png)
Pharmaceutics, Free Full-Text
![](https://www.frontiersin.org/files/Articles/549129/fcell-08-00672-HTML/image_m/fcell-08-00672-g001.jpg)
Frontiers Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
![](https://encyclopedia.pub/media/item/202305/6464751a703abcancers-15-02721-g004-550.jpg)
Molecular Mechanisms of Cancer Immunotherapy
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41422-020-0337-2/MediaObjects/41422_2020_337_Fig1_HTML.png)
The future of cancer immunotherapy: microenvironment-targeting combinations
![](https://www.frontiersin.org/files/Articles/1037945/fimmu-14-1037945-HTML-r1/image_m/fimmu-14-1037945-g001.jpg)
Frontiers Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
![](https://www.mdpi.com/genes/genes-14-01953/article_deploy/html/images/genes-14-01953-g001.png)
Genes, Free Full-Text
![](https://www.mdpi.com/cancers/cancers-15-00184/article_deploy/html/images/cancers-15-00184-g001.png)
Translational Control of Immune Evasion in Cancer: Trends in Cancer, evade controls
![](https://www.frontiersin.org/files/Articles/958720/fonc-12-958720-HTML/image_m/fonc-12-958720-g001.jpg)
Frontiers Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
![](https://www.mdpi.com/ijms/ijms-23-10906/article_deploy/html/images/ijms-23-10906-g001b.png)
IJMS, Free Full-Text